Pine Biotech has secured over $1 million in seed funding from investors in support of the development and commercialization of their proprietary biomedical data analysis and machine learning platform. Incorporated in the end of 2014, Pine Biotech is commercializing a biomedical data analysis platform in collaboration with the Tauber Bioinformatics Research Center and the University of Haifa.


June 20, 2017 — Read more in The Times-Picayune